126
Participants
Start Date
December 10, 2021
Primary Completion Date
October 7, 2024
Study Completion Date
August 29, 2025
AZD0171
AZD0171
Durvalumab
Durvalumab
Gemcitabine
Chemotherapy (Standard-of-Care)
Nab-paclitaxel
Chemotherapy (Standard-of-Care)
Research Site, New York
Research Site, Seongnam-si
Research Site, Buffalo
Research Site, Charlottesville
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Majadahonda
Research Site, Atlanta
Research Site, Pamplona
Research Site, Ann Arbor
Research Site, Grand Rapids
Research Site, Madison
Research Site, San Antonio
Research Site, Coeur d'Alene
Research Site, Los Angeles
Research Site, La Jolla
Research Site, Orange
Research Site, Ventura
Research Site, Portland
Research Site, Seattle
Research Site, Boston
Research Site, Barrie
Research Site, Toronto
Research Site, Toronto
Research Site, Seongnam-si
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Badalona
Research Site, Barcelona
Lead Sponsor
AstraZeneca
INDUSTRY